Current Issue

View Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences

Featured Articles

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey Doyle, Manager, PAT Projects in the Process Analytical Sciences Group
Paul Jeffers, Manager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’Neill, Analytical Chemist
Pfizer

Bringing the Freezing of Biopharmaceuticals in From the Cold

Characterization and Engineering Performance of the Allegro™ STR 500 Single-Use Stirred Tank Bioreactor

Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins

View All Featured Articles

Headline News

Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis

FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold

Moderna advances Bundibugyo ebolavirus vaccine toward Phase II/III study

Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Using In-Vitro Dissolution to Support Post Approval Changes Global Regulatory Expectations

Presented by Xin Bu, Principal Scientist at Bristol-Myers Squibb
05th February 2019

Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L

Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022

Advanced digitalization plan for AstraZeneca’s CDC line

Presented by Melanie Dumarey, Product and process design engineer (associate principal scientist) at AstraZeneca
15th March 2023

View All Past Webinars

Featured Companies

View All Companies

Featured Video

At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.

There’s no kit for the perfect biotech process. Until now.

View All Videos